Drug/chemical-induced diabetes mellitus with moderate nonproliferative retinopathy and bilateral macular edema is a serious condition resulting from the use of certain medications or chemicals that disrupt glucose metabolism. This condition is clinically significant as it can lead to vision impairment and other complications. The ICD-10 Code E09.3313 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code E09.3313 represents drug or chemical-induced diabetes mellitus characterized by moderate nonproliferative retinopathy with bilateral macular edema. This code should be used when documenting cases where diabetes is a direct result of pharmacological agents, highlighting the need for careful monitoring and management of ocular complications associated with the underlying condition.
Drug/chemical-induced diabetes mellitus with moderate nonproliferative retinopathy and bilateral macular edema arises from the adverse effects of certain medications, leading to impaired insulin secretion and glucose intolerance. This condition necessitates prompt medical attention to prevent further ocular damage and systemic complications.
ICD-10 Code E09.3313 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to drug-induced diabetes and its ocular complications. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code E09.3313 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of drug-induced diabetes with ocular complications. This code supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.
Management of drug-induced diabetes with moderate nonproliferative retinopathy and bilateral macular edema requires a multifaceted approach to prevent vision loss and manage blood glucose levels.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E09.3313 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 92014 | Ophthalmological examination, comprehensive, established patient. |
| 83036 | Hemoglobin A1c test for diabetes management. |
Common Questions About Using ICD-10 Code E09.3313 for Drug/chem diab with mod nonp rtnop with macular edema, bi
What medications can cause drug-induced diabetes?
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can lead to drug-induced diabetes by affecting insulin sensitivity or secretion.
How is macular edema treated in patients with drug-induced diabetes?
Treatment for macular edema may include intravitreal injections of anti-VEGF agents, corticosteroids, or laser therapy, depending on the severity and underlying cause.
What are the long-term implications of drug-induced diabetes?
Long-term implications may include an increased risk of cardiovascular disease, neuropathy, and retinopathy, necessitating ongoing monitoring and management.
How often should patients with this condition be monitored?
Patients should be monitored regularly, typically every 3 to 6 months, to assess blood glucose levels and ocular health, adjusting treatment as necessary.
Clinical Notes
SOAP notes
DAP notes
AI medical notes